ilomastat has been researched along with 17,20,21-trihydroxy-4-pregnen-3-one in 1 studies
| Studies (ilomastat) | Trials (ilomastat) | Recent Studies (post-2010) (ilomastat) | Studies (17,20,21-trihydroxy-4-pregnen-3-one) | Trials (17,20,21-trihydroxy-4-pregnen-3-one) | Recent Studies (post-2010) (17,20,21-trihydroxy-4-pregnen-3-one) |
|---|---|---|---|---|---|
| 103 | 0 | 45 | 38 | 1 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, W; Thomas, P | 1 |
1 other study(ies) available for ilomastat and 17,20,21-trihydroxy-4-pregnen-3-one
| Article | Year |
|---|---|
Involvement of epidermal growth factor receptors and mitogen-activated protein kinase in progestin-induction of sperm hypermotility in Atlantic croaker through membrane progestin receptor-alpha.
Topics: Animals; Cortodoxone; ErbB Receptors; Fish Proteins; Hydroxamic Acids; Indoles; Male; Mitogen-Activated Protein Kinases; Perciformes; Progestins; Pyrimidines; Receptor, ErbB-2; Signal Transduction; Sperm Motility | 2015 |